Savara Inc earnings releases SVRA

Annual Quarterly

Savara Inc last reported quarterly results on Aug 6, 2020, for the quarter ended Jun 30, 2020. It usually reports 37–72 days after a quarter ends.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 37–72 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released	Quarter	Revenue	Net income	Diluted EPS
Aug 6, 2020 37 days after quarter end	— ended Jun 30, 2020	—	—	—
May 7, 2020 37 days after quarter end	— ended Mar 31, 2020	—	—	—
Mar 12, 2020 72 days after quarter end	— ended Dec 31, 2019	—	—	—
Nov 7, 2019 38 days after quarter end	— ended Sep 30, 2019	—	—	—
Aug 8, 2019 39 days after quarter end	— ended Jun 30, 2019	—	—	—
May 9, 2019 39 days after quarter end	— ended Mar 31, 2019	—	—	—
Mar 13, 2019 72 days after quarter end	— ended Dec 31, 2018	—	—	—
Nov 7, 2018 38 days after quarter end	— ended Sep 30, 2018	—	—	—

Company profile

Industry: Pharmaceutical Preparations (SIC 2834)
Listed as: SVRA (Nasdaq)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: Austin, TX
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 1160308
Former names: Mast Therapeutics, Inc. (until Apr 25, 2017); ADVENTRX PHARMACEUTICALS INC (until Mar 1, 2013); BIOKEYS PHARMACEUTICALS INC (until May 15, 2003)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.